•
Mar 31, 2023

ARS Pharmaceuticals Q1 2023 Earnings Report

Total Revenue
$20K
Previous year: $663K
-97.0%
EPS
-$0.16
Previous year: -$0.24
-33.3%
Gross Profit
-$6.53M
Previous year: -$4.76M
+37.2%
Cash and Equivalents
$87.9M
Previous year: $234M
-62.5%
Free Cash Flow
-$12.6M
Previous year: -$6.95M
+81.7%
Total Assets
$271M
Previous year: $312M
-13.2%

ARS Pharmaceuticals

ARS Pharmaceuticals